1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Expression Vectors Market by Host Type, Application, End User - Forecast to 2020

The expression vectors market is expected to reach $317.1 million by 2020 from $242.7 million in 2015, growing at a CAGR of 5.5% from 2015 to 2020. The market is categorized on the basis of host type, application, end user, and region. The application market includes therapeutic, research, and industrial applications. The therapeutic applications segment is expected to grow at the highest CAGR in the coming five years.

Major factors contributing to the growth of the global expression vectors market include increasing demand of protein-based drugs (biologics); high prevalence of lifestyle diseases, infectious diseases, and genetic disorders; and increasing funding for protein research. For instance, in September 2014, AbCelex Technologies Inc., a privately held Canadian biotechnology company, received a venture capital fund of $1 million by Pinetree Capital Corporation for development of the company’s protein expression systems and antibody engineering techniques. Funding for protein research helps the expression vectors market to grow as it is an integral component of it.

The Asian expression vectors market is the fastest-growing market, globally. With huge man power and cost-effective manufacturing facilities, several market players are focusing on expanding their presence in the Asian countries. For instance, in November 2012, Promega Corporation (U.S.), a provider of expression vectors, opened a new facility in Shanghai, Shanghai Promega Life Science Center. This facility manufactures biological and chemical regents and instruments used in life science research and molecular diagnostics. Establishment of such facilities helps the local market with easy product availability and services.

Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the expression vectors market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on the product portfolios of the top players in the expression vectors market. The report analyzes this market by host type, application, end user, and region
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the expression vectors market
- Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the expression vectors market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various expression vector products across regions
- Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the expression vectors market

Table Of Contents

Expression Vectors Market by Host Type, Application, End User - Forecast to 2020
TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKET SEGMENTATION 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 MARKET STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 MARKET SIZE ESTIMATION 19
2.2 MARKET BREAKDOWN and DATA TRIANGULATION 22
2.3 KEY DATA FROM SECONDARY SOURCES 23
2.4 KEY DATA FROM PRIMARY SOURCES 23
2.5 KEY INDUSTRY INSIGHTS 24
2.6 ASSUMPTIONS FOR THE STUDY 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 29
4.1 EXPRESSION VECTORS MARKET, BY HOST TYPE 29
4.2 EXPRESSION VECTORS MARKET, BY APPLICATION 31
4.3 EXPRESSION VECTORS MARKET, BY END USERS 32
4.4 EXPRESSION VECTORS MARKET, BY REGION 33
5 MARKET OVERVIEW 34
5.1 INTRODUCTION 35
5.1.1 BY HOST TYPE 35
5.1.2 BY APPLICATION 35
5.1.3 BY END USER 36
5.1.4 BY REGION 36
5.2 MARKET DYNAMICS 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 High prevalence rate of lifestyle diseases, infectious diseases, and genetic disorders 38
5.2.1.2 Increase in demand for protein-based therapeutic agents 38
5.2.1.3 Funding for protein research 38

5.2.2 MARKET RESTRAINT 39
5.2.2.1 High cost of protein therapy 39
5.2.3 OPPORTUNITY 40
5.2.3.1 Developing countries 40
5.2.4 CHALLENGE 40
5.2.4.1 Sequestration cuts in the U.S. 40
6 EXPRESSION VECTORS MARKET, BY HOST TYPE 41
6.1 INTRODUCTION 42
6.2 BACTERIAL EXPRESSION VECTORS 43
6.2.1 E.COLI EXPRESSION VECTORS 44
6.2.2 OTHER BACTERIAL EXPRESSION VECTORS 45
6.3 MAMMALIAN EXPRESSION VECTORS 47
6.3.1 CHO EXPRESSION VECTORS 49
6.3.2 OTHER MAMMALIAN EXPRESSION VECTORS 50
6.4 INSECT EXPRESSION VECTORS 51
6.4.1 BACULOVIRUS EXPRESSION VECTORS 52
6.4.2 OTHER INSECT EXPRESSION VECTORS 53
6.5 YEAST EXPRESSION VECTORS 54
6.5.1 K. LACTIS EXPRESSION VECTORS 56
6.5.2 PICHIA PASTORIS EXPRESSION VECTORS 57
6.5.3 SACCHAROMYCES CEREVISIAE EXPRESSION VECTORS 58
6.5.4 OTHER YEAST EXPRESSION VECTORS 59
6.6 OTHER EXPRESSION VECTORS 61
7 EXPRESSION VECTORS MARKET, BY APPLICATION 62
7.1 INTRODUCTION 63
7.2 THERAPEUTIC APPLICATIONS 64
7.3 INDUSTRIAL APPLICATIONS 66
7.4 RESEARCH APPLICATIONS 68
8 EXPRESSION VECTORS MARKET, BY END USER 70
8.1 INTRODUCTION 71
8.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 73
8.3 CROS AND CMOS 74
8.4 ACADEMIC RESEARCH INSTITUTES 76
8.5 OTHER END USERS 77
9 GLOBAL EXPRESSION VECTORS MARKET, BY REGION 79
9.1 INTRODUCTION 80
9.2 NORTH AMERICA 81
9.2.1 U.S. 86
9.2.2 CANADA 89
9.3 EUROPE 92
9.4 ASIA 97
9.5 REST OF THE WORLD (ROW) 101
10 COMPETITIVE LANDSCAPE 106
10.1 OVERVIEW 106
10.2 MARKET SHARE ANALYSIS 107
10.3 COMPETITIVE SITUATION AND TRENDS 108
10.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 109
10.3.2 EXPANSIONS 111
10.3.3 ACQUISITIONS 111
10.3.4 NEW PRODUCT LAUNCHES 112
11 COMPANY PROFILES 113
11.1 INTRODUCTION 113
11.2 MERCK MILLIPORE (A SUBSIDIARY OF MERCK KGAA) 114
11.2.1 BUSINESS OVERVIEW 114
11.2.2 PRODUCT OFFERINGS 115
11.2.3 RECENT DEVELOPMENTS 115
11.2.4 MNM VIEW 115
11.3 THERMO FISHER SCIENTIFIC, INC. 116
11.3.1 BUSINESS OVERVIEW 116
11.3.2 PRODUCT OFFERINGS 117
11.3.3 RECENT DEVELOPMENTS 117
11.3.4 MNM VIEW 117
11.4 SIGMA-ALDRICH CORPORATION 118
11.4.1 BUSINESS OVERVIEW 118
11.4.2 PRODUCT OFFERINGS 118
11.4.3 RECENT DEVELOPMENTS 119
11.4.4 MNM VIEW 119
11.5 PROMEGA CORPORATION 120
11.5.1 BUSINESS OVERVIEW 120
11.5.2 PRODUCT OFFERINGS 120
11.5.3 RECENT DEVELOPMENTS 120
11.5.4 MNM VIEW 120
11.6 CLONTECH LABORATORIES, INC. 121
11.6.1 BUSINESS OVERVIEW 121
11.6.2 PRODUCT OFFERINGS 122
11.6.3 RECENT DEVELOPMENTS 123
11.6.4 MNM VIEW 123

11.7 AGILENT TECHNOLOGIES 124
11.7.1 BUSINESS OVERVIEW 124
11.7.2 PRODUCT OFFERINGS 125
11.7.3 RECENT DEVELOPMENTS 125
11.8 BIO-RAD LABORATORIES, INC. 126
11.8.1 BUSINESS OVERVIEW 126
11.8.2 PRODUCT OFFERINGS 127
11.8.3 RECENT DEVELOPMENTS 127
11.9 DNA2.0, INC. 128
11.9.1 BUSINESS OVERVIEW 128
11.9.2 PRODUCT OFFERINGS 128
11.9.3 RECENT DEVELOPMENTS 129
11.10 NEW ENGLAND BIOLABS (NEB) 130
11.10.1 BUSINESS OVERVIEW 130
11.10.2 PRODUCT OFFERINGS 130
11.10.3 RECENT DEVELOPMENTS 130
11.11 QIAGEN 131
11.11.1 BUSINESS OVERVIEW 131
11.11.2 PRODUCT OFFERINGS 132
11.11.3 RECENT DEVELOPMENTS 132
12 APPENDIX 133
12.1 INSIGHTS FROM INDUSTRY EXPERTS 133
12.2 DISCUSSION GUIDE 134
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 136
12.4 AVAILABLE CUSTOMIZATIONS 136
12.5 RELATED REPORTS 137


LIST OF TABLES

TABLE 1 INCREASE IN DEMAND FOR PROTEIN-BASED THERAPEUTIC AGENTS IS BOOSTING MARKET GROWTH 39
TABLE 2 HIGH COST OF PROTEIN THERAPY ACTS AS A RESTRAINT TO THE GROWTH OF THE EXPRESSION VECTORS MARKET 39
TABLE 3 DEVELOPING COUNTRIES TO OFFER AN ARRAY OF OPPORTUNITIES 40
TABLE 4 SEQUESTRATION CUTS IN THE U.S. POSE SIGNIFICANT CHALLENGES TO MARKET GROWTH 40
TABLE 5 EXPRESSION VECTORS MARKET SIZE, BY HOST TYPE, 2013-2020 ($MILLION) 43
TABLE 6 BACTERIAL EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 43
TABLE 7 BACTERIAL EXPRESSION VECTORS MARKET SIZE, BY REGION,
2013-2020 ($MILLION) 44
TABLE 8 NORTH AMERICA: BACTERIAL EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 44
TABLE 9 E.COLI EXPRESSION VECTORS MARKET SIZE, BY REGION, 2013-2020 ($MILLION) 45
TABLE 10 NORTH AMERICA: E.COLI EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 45
TABLE 11 OTHER BACTERIAL EXPRESSION VECTORS MARKET SIZE, BY REGION,
2013-2020 ($MILLION) 46
TABLE 12 NORTH AMERICA: OTHER BACTERIAL EXPRESSION VECTORS MARKET SIZE,
BY COUNTRY, 2013-2020 ($MILLION) 46
TABLE 13 MAMMALIAN EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 47
TABLE 14 MAMMALIAN EXPRESSION VECTORS MARKET SIZE, BY REGION,
2013-2020 ($MILLION) 48
TABLE 15 NORTH AMERICA: MAMMALIAN EXPRESSION VECTORS MARKET SIZE,
BY COUNTRY, 2013-2020 ($MILLION) 48
TABLE 16 CHO EXPRESSION VECTORS MARKET SIZE, BY REGION, 2013-2020 ($MILLION) 49
TABLE 17 NORTH AMERICA: CHO EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 49
TABLE 18 OTHER MAMMALIAN EXPRESSION VECTORS MARKET SIZE, BY REGION,
2013-2020 ($MILLION) 50
TABLE 19 NORTH AMERICA: OTHER MAMMALIAN EXPRESSION VECTORS MARKET SIZE,
BY COUNTRY, 2013-2020 ($MILLION) 50
TABLE 20 INSECT EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION) 51
TABLE 21 INSECT EXPRESSION VECTORS MARKET SIZE, BY REGION, 2013-2020 ($MILLION) 51
TABLE 22 NORTH AMERICA: INSECT EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 52
TABLE 23 BACULOVIRUS EXPRESSION VECTORS MARKET SIZE, BY REGION,
2013-2020 ($MILLION) 52
TABLE 24 NORTH AMERICA: BACULOVIRUS EXPRESSION VECTORS MARKET SIZE,
BY COUNTRY, 2013-2020 ($MILLION) 53
TABLE 25 OTHER INSECT EXPRESSION VECTORS MARKET SIZE, BY REGION,
2013-2020 ($THOUSAND) 53
TABLE 26 NORTH AMERICA: OTHER INSECT EXPRESSION VECTORS MARKET SIZE,
BY COUNTRY, 2013-2020 ($THOUSAND) 54
TABLE 27 YEAST EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION) 55
TABLE 28 YEAST EXPRESSION VECTORS MARKET SIZE, BY REGION, 2013-2020 ($MILLION) 56
TABLE 29 NORTH AMERICA: YEAST EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 56
TABLE 30 K. LACTIS EXPRESSION VECTORS MARKET SIZE, BY REGION,
2013-2020 ($MILLION) 57
TABLE 31 NORTH AMERICA: K. LACTIS EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 57
TABLE 32 P. PASTORIS EXPRESSION VECTORS MARKET SIZE, BY REGION,
2013-2020 ($MILLION) 58
TABLE 33 NORTH AMERICA: P. PASTORIS EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 58
TABLE 34 S. CEREVISIAE EXPRESSION VECTORS MARKET SIZE, BY REGION,
2013-2020 ($MILLION) 59
TABLE 35 NORTH AMERICA: S. CEREVISIAE EXPRESSION VECTORS MARKET SIZE,
BY COUNTRY, 2013-2020 ($MILLION) 59
TABLE 36 OTHER YEAST EXPRESSION VECTORS, BY REGION, 2013-2020 ($THOUSAND) 60
TABLE 37 NORTH AMERICA: OTHER YEAST EXPRESSION VECTORS MARKET SIZE,
BY COUNTRY, 2013-2020 ($THOUSAND) 60
TABLE 38 OTHER EXPRESSION VECTORS MARKET SIZE, BY REGION, 2013-2020 ($MILLION) 61
TABLE 39 NORTH AMERICA: OTHER EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 61
TABLE 40 EXPRESSION VECTORS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION) 63
TABLE 41 EXPRESSION VECTORS MARKET SIZE FOR THERAPEUTIC APPLICATIONS,
BY REGION, 2013-2020 ($MILLION) 65
TABLE 42 NORTH AMERICA: EXPRESSION VECTORS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2013-2020 ($MILLION) 66
TABLE 43 EXPRESSION VECTORS MARKET SIZE FOR INDUSTRIAL APPLICATIONS, BY REGION, 2013-2020 ($MILLION) 67
TABLE 44 NORTH AMERICA: EXPRESSION VECTORS MARKET SIZE FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2013-2020 ($MILLION) 67
TABLE 45 EXPRESSION VECTORS MARKET SIZE FOR RESEARCH APPLICATIONS, BY REGION, 2013-2020 ($MILLION) 68
TABLE 46 NORTH AMERICA: EXPRESSION VECTORS MARKET SIZE FOR RESEARCH APPLICATIONS, BY COUNTRY, 2013-2020 ($MILLION) 69
TABLE 47 EXPRESSION VECTORS MARKET SIZE, BY END USER, 2013-2020 ($MILLION) 72
TABLE 48 EXPRESSION VECTORS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2020 ($MILLION) 73
TABLE 49 NORTH AMERICA: EXPRESSION VECTORS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2020 ($MILLION) 74
TABLE 50 EXPRESSION VECTORS MARKET SIZE FOR CROS AND CMOS, BY REGION,
2013-2020 ($MILLION) 75
TABLE 51 NORTH AMERICA: EXPRESSION VECTORS MARKET SIZE FOR CROS AND CMOS,
BY COUNTRY, 2013-2020 ($MILLION) 75
TABLE 52 EXPRESSION VECTORS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES,
BY REGION, 2013-2020 ($MILLION) 76
TABLE 53 NORTH AMERICA: EXPRESSION VECTORS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2013-2020 ($MILLION) 77
TABLE 54 EXPRESSION VECTORS MARKET SIZE FOR OTHER END USERS, BY REGION,
2013-2020 ($MILLION) 77
TABLE 55 NORTH AMERICA: EXPRESSION VECTORS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2013-2020 ($MILLION) 78
TABLE 56 EXPRESSION VECTORS MARKET SIZE, BY REGION, 2013-2020 ($MILLION) 80
TABLE 57 NORTH AMERICA: EXPRESSION VECTORS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 83
TABLE 58 NORTH AMERICA: EXPRESSION VECTORS MARKET SIZE, BY HOST TYPE,
2013-2020 ($MILLION) 83
TABLE 59 NORTH AMERICA: BACTERIAL EXPRESSION VECTORS MARKET SIZE,
BY TYPE, 2013-2020 ($MILLION) 83
TABLE 60 NORTH AMERICA: MAMMALIAN EXPRESSION VECTORS MARKET SIZE,
BY TYPE, 2013-2020 ($MILLION) 84
TABLE 61 NORTH AMERICA: YEAST EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 84
TABLE 62 NORTH AMERICA: INSECT EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 85
TABLE 63 NORTH AMERICA: EXPRESSION VECTORS MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION) 85
TABLE 64 NORTH AMERICA: EXPRESSION VECTORS MARKET SIZE, BY END USER,
2013-2020 ($MILLION) 85
TABLE 65 U.S.: EXPRESSION VECTORS MARKET SIZE, BY HOST TYPE,
2013-2020 ($MILLION) 87
TABLE 66 U.S.: BACTERIAL EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 87
TABLE 67 U.S.: MAMMALIAN EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 87
TABLE 68 U.S.: YEAST EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 88
TABLE 69 U.S.: INSECT EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 88
TABLE 70 U.S.: EXPRESSION VECTORS MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION) 88
TABLE 71 U.S.: EXPRESSION VECTORS MARKET SIZE, BY END USER, 2013-2020 ($MILLION) 89
TABLE 72 CANADA: EXPRESSION VECTORS MARKET SIZE, BY HOST TYPE,
2013-2020 ($MILLION) 90
TABLE 73 CANADA: BACTERIAL EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 90
TABLE 74 CANADA: MAMMALIAN EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 90
TABLE 75 CANADA: YEAST EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 91
TABLE 76 CANADA: INSECT EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 91
TABLE 77 CANADA: EXPRESSION VECTORS MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION) 91
TABLE 78 CANADA: EXPRESSION VECTORS MARKET SIZE, BY END USER,
2013-2020 ($MILLION) 92
TABLE 79 EUROPE: EXPRESSION VECTORS MARKET SIZE, BY HOST TYPE,
2013-2020 ($MILLION) 95
TABLE 80 EUROPE: BACTERIAL EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 95
TABLE 81 EUROPE: MAMMALIAN EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 95
TABLE 82 EUROPE: YEAST EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 96
TABLE 83 EUROPE: INSECT EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 96
TABLE 84 EUROPE: EXPRESSION VECTORS MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION) 96
TABLE 85 EUROPE: EXPRESSION VECTORS MARKET SIZE, BY END USER,
2013-2020 ($MILLION) 97
TABLE 86 ASIA: EXPRESSION VECTORS MARKET SIZE, BY HOST TYPE,
2013-2020 ($MILLION) 99
TABLE 87 ASIA: BACTERIAL EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 99
TABLE 88 ASIA: MAMMALIAN EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 99
TABLE 89 ASIA: YEAST EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 100
TABLE 90 ASIA: INSECT EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 100
TABLE 91 ASIA: EXPRESSION VECTORS MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION) 100
TABLE 92 ASIA: EXPRESSION VECTORS MARKET SIZE, BY END USER,
2013-2020 ($MILLION) 101
TABLE 93 ROW: EXPRESSION VECTORS MARKET SIZE, BY HOST TYPE,
2013-2020 ($MILLION) 103
TABLE 94 ROW: BACTERIAL EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 103
TABLE 95 ROW: MAMMALIAN EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 103
TABLE 96 ROW: YEAST EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 104
TABLE 97 ROW: INSECT EXPRESSION VECTORS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 104
TABLE 98 ROW: EXPRESSION VECTORS MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION) 104
TABLE 99 ROW: EXPRESSION VECTORS MARKET SIZE, BY END USER,
2013-2020 ($MILLION) 105
TABLE 100 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2012-2015 109
TABLE 101 EXPANSIONS, 2012-2015 111
TABLE 102 ACQUISITIONS, 2013-2014 111
TABLE 103 NEW PRODUCT LAUNCHES, 2012-2014 112


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 18
FIGURE 2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 20
FIGURE 3 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 21
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 21
FIGURE 5 DATA TRIANGULATION METHODOLOGY 22
FIGURE 6 EXPRESSION VECTORS MARKET SNAPSHOT, BY HOST TYPE (2015 VS. 2020) 25
FIGURE 7 CROS AND CMOS FORM THE FASTEST-GROWING END-USER SEGMENT 26
FIGURE 8 EXPRESSION VECTORS MARKET, BY APPLICATION (2015-2020): THERAPEUTIC APPLICATIONS TO WITNESS HIGHEST GROWTH 27
FIGURE 9 GLOBAL EXPRESSION VECTORS MARKET, BY REGION: NORTH AMERICA EXPECTED TO HOLD THE LARGEST SHARE IN 2015 28
FIGURE 10 MAMMALIAN EXPRESSION VECTORS MARKET TO GROW AT THE HIGHEST CAGR FROM 2015 TO 2020 29
FIGURE 11 BACTERIAL, MAMMALIAN, AND INSECT EXPRESSION VECTORS: MAJOR MARKET SEGMENTS IN 2015 30
FIGURE 12 THERAPEUTIC APPLICATIONS TO WITNESS HIGHEST GROWTH RATE IN THE FORECAST PERIOD 31
FIGURE 13 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO COMMAND THE LARGEST SHARE IN 2015 32
FIGURE 14 ASIA TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD 33
FIGURE 15 EXPRESSION VECTORS MARKET SEGMENTATION: BY HOST TYPE 35
FIGURE 16 EXPRESSION VECTORS MARKET SEGMENTATION: BY APPLICATION 35
FIGURE 17 EXPRESSION VECTORS MARKET SEGMENTATION: BY END USER 36
FIGURE 18 EXPRESSION VECTORS MARKET SEGMENTATION: BY REGION 36
FIGURE 19 INCREASE IN DEMAND FOR PROTEIN-BASED DRUGS TO PROPEL MARKET GROWTH 37
FIGURE 20 MAMMALIAN EXPRESSION VECTORS TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD 42
FIGURE 21 K. LACTIS EXPRESSION VECTORS TO WITNESS HIGHEST GROWTH 55
FIGURE 22 THERAPEUTIC APPLICATIONS: FASTEST-GROWING APPLICATION SEGMENT 63
FIGURE 23 THERAPEUTIC APPLICATIONS: ASIA TO SHOW HIGHEST GROWTH 65
FIGURE 24 END-USER BASE: EXPRESSION VECTORS MARKET 71
FIGURE 25 CROS AND CMOS, A HIGH-GROWTH END-USER SEGMENT IN THE MARKET 72
FIGURE 26 ASIA, AN ATTRACTIVE DESTINATION FOR ALL APPLICATIONS IN THE EXPRESSION VECTORS MARKET 80
FIGURE 27 NORTH AMERICA HOLDS THE LARGEST SHARE OF THE GLOBAL EXPRESSION VECTORS MARKET (2015) 82
FIGURE 28 EUROPEAN EXPRESSION VECTORS MARKET SNAPSHOT 94
FIGURE 29 ASIAN EXPRESSION VECTORS MARKET TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 98
FIGURE 30 ROW EXPRESSION VECTORS MARKET SNAPSHOT 102
FIGURE 31 MAJOR PLAYERS PURSUED INORGANIC GROWTH STRATEGIES BETWEEN
2012 and 2015 106
FIGURE 32 GLOBAL EXPRESSION VECTORS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014 107
FIGURE 33 MARKET EVOLUTION FRAMEWORK: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS and EXPANSIONS FUELLED MARKET GROWTH 108
FIGURE 34 BATTLE FOR MARKET SHARE: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS WAS THE KEY STRATEGY 109
FIGURE 35 GEOGRAPHIC REVENUE MIX OF KEY MARKET PLAYERS 113
FIGURE 36 MERCK MILLIPORE: COMPANY SNAPSHOT 114
FIGURE 37 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 116
FIGURE 38 SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT 118
FIGURE 39 TAKARA BIO, INC.: COMPANY SNAPSHOT 121
FIGURE 40 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT 124
FIGURE 41 BIO-RAD LABORATORIES: COMPANY SNAPSHOT 126
FIGURE 42 QIAGEN: COMPANY SNAPSHOT 131

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PDE Inhibitors Market, 2016-2026

PDE Inhibitors Market, 2016-2026

  • $ 2349
  • Industry report
  • October 2016
  • by Roots Analysis Private Ltd.

INTRODUCTION The discovery of the second messengers, cAMP and cGMP, in 1958 led to a deeper understanding of the signal transduction processes behind physiological stimulation and response. Later, the ...

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global bioinformatics market is projected to reach USD 16.18 billion by 2021 from USD 6.21 billion in 2016, growing at a CAGR of 21.1% during the forecast period. In this report, the bioinformatics ...

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.